Fujifilm Starts Clinical Trial of Anti-Viral Drug for COVID-19 Patients

0

Fujifilm has announced it is starting clinical trials of an antiviral drug called Avigan (the generic name is favipiravir) for patients with COVID-19, the respiratory infection caused by the novel coronavirus. In March, reports out of China indicated that the drug seemed to help COVID-19 patients recover (see “Fujifilm Drug Raises Hopes in Fight against

To see the rest of this post, please view membership options or log in to your account below.

Share.